GLIMYES-VM (Voglibose + Glimepiride + Metformin)

MOA

1. Voglibose delays carbohydrate absorption
2. Reduces postprandial glucose spike
3. Glimepiride increases insulin secretion
4. Metformin reduces hepatic glucose output
5. Improves insulin sensitivity
6. Enhances glucose utilization
7. Provides triple control

Uses

1. Type 2 diabetes
2. Postprandial hyperglycemia
3. Poor glycemic control
4. Combination therapy
5. Obese diabetics
6. High HbA1c
7. Long-term diabetes control

Side Effects

1. Hypoglycemia
2. Flatulence
3. Diarrhea
4. Nausea
5. Abdominal discomfort
6. Weight gain
7. Dizziness

Precautions

1. Take with meals
2. Monitor sugar levels
3. Avoid alcohol
4. Watch for hypoglycemia
5. Monitor kidney function
6. Adjust dose carefully
7. Use under supervision

Tags: VOGLIBOSE 0.2 MG+ GLIMEPIRIDE 2 MG+ METFORMIN HYDROCHLORIDE 500 MG